PT91006A - Processo para a preparacao de um novo sal de estroncio - Google Patents

Processo para a preparacao de um novo sal de estroncio

Info

Publication number
PT91006A
PT91006A PT91006A PT9100689A PT91006A PT 91006 A PT91006 A PT 91006A PT 91006 A PT91006 A PT 91006A PT 9100689 A PT9100689 A PT 9100689A PT 91006 A PT91006 A PT 91006A
Authority
PT
Portugal
Prior art keywords
new
salt
estroncio
preparation
pyrrol
Prior art date
Application number
PT91006A
Other languages
English (en)
Other versions
PT91006B (pt
Inventor
Jacqueline Bonnet
Michel Wierzbicki
Yannis Tsouderos
Original Assignee
Obrecht Gary W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obrecht Gary W filed Critical Obrecht Gary W
Publication of PT91006A publication Critical patent/PT91006A/pt
Publication of PT91006B publication Critical patent/PT91006B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT91006A 1988-06-29 1989-06-28 Processo para a preparacao de um novo sal de estroncio PT91006B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808729A FR2633619B1 (fr) 1988-06-29 1988-06-29 Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant

Publications (2)

Publication Number Publication Date
PT91006A true PT91006A (pt) 1989-12-29
PT91006B PT91006B (pt) 1994-11-30

Family

ID=9367847

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91006A PT91006B (pt) 1988-06-29 1989-06-28 Processo para a preparacao de um novo sal de estroncio

Country Status (16)

Country Link
US (1) US4939164A (pt)
EP (1) EP0349432B1 (pt)
JP (1) JPH0248567A (pt)
AT (1) ATE81118T1 (pt)
AU (1) AU613297B2 (pt)
CA (1) CA1312333C (pt)
DE (1) DE68903059T2 (pt)
DK (1) DK325289A (pt)
ES (1) ES2044170T3 (pt)
FR (1) FR2633619B1 (pt)
GR (1) GR3006674T3 (pt)
IE (1) IE64112B1 (pt)
NZ (1) NZ229760A (pt)
OA (1) OA09121A (pt)
PT (1) PT91006B (pt)
ZA (1) ZA894945B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
EP1534305B9 (en) * 2003-05-07 2007-03-07 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
WO2005082385A1 (en) * 2004-02-26 2005-09-09 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
EP2266584B1 (en) * 2003-05-07 2012-09-05 Osteologix A/S Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions
EA011814B1 (ru) 2004-06-25 2009-06-30 Стронтин Апс Композиции, содержащие стронций и витамин d, и их применение
US7875627B2 (en) * 2004-12-07 2011-01-25 Abbott Laboratories Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
US10183308B2 (en) 2014-10-14 2019-01-22 Conopco, Inc. Spraying device
EP3207188A1 (en) 2014-10-14 2017-08-23 Unilever NV Device for spraying an enclosure triggered by inclination of a rotatable lid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954384A (en) * 1960-09-27 Method for preparing kainic acid and its
DE3127275A1 (de) * 1980-12-11 1983-01-27 Leskovar, Peter, Dr.-Ing., 8000 München "harnsteinaufloesende mittel"

Also Published As

Publication number Publication date
ZA894945B (en) 1990-03-28
EP0349432A1 (fr) 1990-01-03
IE64112B1 (en) 1995-07-12
PT91006B (pt) 1994-11-30
OA09121A (fr) 1991-10-31
EP0349432B1 (fr) 1992-09-30
ES2044170T3 (es) 1994-01-01
JPH0587064B2 (pt) 1993-12-15
IE892094L (en) 1989-12-29
JPH0248567A (ja) 1990-02-19
AU3709289A (en) 1990-01-04
DK325289A (da) 1989-12-30
AU613297B2 (en) 1991-07-25
FR2633619B1 (fr) 1991-02-08
DK325289D0 (da) 1989-06-29
NZ229760A (en) 1991-06-25
CA1312333C (fr) 1993-01-05
GR3006674T3 (pt) 1993-06-30
ATE81118T1 (de) 1992-10-15
DE68903059D1 (de) 1992-11-05
US4939164A (en) 1990-07-03
FR2633619A1 (fr) 1990-01-05
DE68903059T2 (de) 1993-04-29

Similar Documents

Publication Publication Date Title
PT88200A (pt) Processo para a preparacao de uma composicao para o tratamento da pele
PT88261A (pt) Processo para a preparacao de nucleosidos com efeito terapeutico
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
AU1808488A (en) Compounds for the treatment of alzheimer's disease
DK90888D0 (da) Maaleapparat til vaevsmetabolisme
IS3529A7 (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkum bis-aza-bísýklískum efnasamböndum
PT87647A (pt) Process for the preparation of interchanging ions resins carried with quinolonocarboxylic acids derivatives and of veterinaries compounds for the treatment of mastitis which contain them
PT93959A (pt) Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima
PT96352A (pt) Processo para a preparacao de uma composicao aperfeicoada para tratamento capilar
PT91006A (pt) Processo para a preparacao de um novo sal de estroncio
DK241287A (da) Anvendelse af glutamin til fremstilling af et laegemiddel til behandling af kataboliske forstyrrelser
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
BR8806062A (pt) Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
PT92228A (pt) Processo para a preparacao de uma formulacao oral liquida, contendo diclofenac
BR8907252A (pt) Corpo de gel e processo para realizar o controle biologico de um processo de esterilizacao
FR2580667B1 (fr) Procede de preparation enzymatique de l-amino acides renfermant du soufre
BR9006502A (pt) Composto e processo para a sua producao,composicao farmaceutica e metodo para o tratamento de um animal hospedeiro
DK585984A (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
KR880002525A (ko) 뇌 허혈성 병을 수반하는 질환 치료제
NO178622C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive kynurensyrederivater, samt mellomprodukter egnet for fremstilling derav
IL90333A0 (en) Process for the racemization of optically active d-2-n-phenacetyl-amino-4-methyl-phosphinobutyric acid
PT88259A (pt) Processo para a preparacao de composicoes farmaceuticas contendo factor atrionatriuretico para o tratamento de doencas cardiacas
EP0302799A3 (en) Process for the preparation of l,l or d,d or racemic n6-benzyloxycarbonyl-2,6-diamino-pimelamic acid
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940518

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19961130